Incyte to Buy Vega Therapeutics For Up to $2 Billion
Incyte has agreed to buy Vega Therapeutics for up to $2 billion in a deal that expands the biopharmaceutical company’s hematology portfolio into bleeding disorders.
Connecting Global Economies
Flash News
Rockets mailbag: Should Houston enter the Giannis Antetokounmpo market?
Johnson & Johnson to Buy Firefly Bio for $1 Billion
Opinion | Why Hong Kong matters to Kazakhstan’s financial ambitions
United CEO brushes off airline mergers after American rejection
British Artist Talay Riley Dead at 35 After Stabbing Incident
Iranian team wears #168 pins for victims of school strike: Will it be allowed during the World Cup?
Incyte to Buy Vega Therapeutics For Up to $2 Billion
WHO chief visits Ebola-hit Uganda after virus spreads from DRC
USAA to return nearly $1 billion to Florida members as legal reforms help lower insurance costs
Why SEC breakaway talk picked up, outlooks for new coaches and more: Mailbag
Monday, June 08, 2026